1 prodrugs could enhance the effectiveness of
adoptive cancer immunotherapy with gammadelta T cells.
2 , we evaluated the safety and efficacy of an
adoptive CD4(+) T-cell therapy using an MHC class II-res
3 pcoming studies, and how novel therapies and
adoptive cell combinations can be used for personalised
4 Despite the promising efficacy of
adoptive cell therapies (ACT) in melanoma, complete resp
5 Adoptive cell therapy (ACT) trials to date have focused
6 xosomes interfere with immune cells used for
adoptive cell therapy and may limit expected therapeutic
7 the cytotoxic effector functions of TCM for
adoptive cell therapy applications.
8 d the foundation of cellular engineering for
adoptive cell therapy in cancer and other diseases.
9 that a viable strategy to improve anti-tumor
adoptive cell therapy may be to engineer tumor-restricte
10 Adoptive cell therapy of chronic lymphocytic leukemia (C
11 could be used to enhance vaccine efficacy or
adoptive cell therapy treatments that target cancer.
12 This study summarizes the use of
adoptive cell therapy, tumor vaccines, immune checkpoint
13 of TGF-beta, suggesting a novel approach to
adoptive cell therapy.
14 d may limit expected therapeutic benefits of
adoptive cell therapy.
15 unotherapies such as checkpoint blockade and
adoptive cell therapy.
16 rs to favorably condition CD8(+) T cells for
adoptive cell therapy.
17 such as administration of the cytokine IL-2,
adoptive cell transfer (ACT) and the recent success of b
18 umor microenvironment (TME), the efficacy of
adoptive cell transfer (ACT) is much curtailed in treati
19 its functional loss reduces the efficacy of
adoptive cell transfer and checkpoint blockade immunothe
20 ls, with potential clinical implications for
adoptive cell transfer and vaccine-based immunotherapies
21 eric antigen receptor (CAR) for T-cell-based
adoptive cell transfer are among these developments that
22 Furthermore, use of gene-deficient mice and
adoptive cell transfer experiments revealed that ILC2s w
23 ion of the lung and improves the efficacy of
adoptive cell transfer immunotherapy.
24 re analyzed using cytokine reporter mice, an
adoptive cell transfer model, and gene knockout mice.
25 Using
adoptive cell transfer studies in mouse models of allerg
26 Adoptive cell transfer utilizing tumour-targeting cytoto
27 Adoptive cell transfer, the infusion of large numbers of
28 Upon
adoptive cell transfer, the T cells isolated from the me
29 and regress multiple solid tumors following
adoptive cell transfer.
30 ine delivery or optimal T cell expansion for
adoptive cell transfer.
31 Finally,
adoptive cell transfers were performed to characterize t
32 ns and reducing the therapeutic potential of
adoptive cell transfers.
33 SG-MSCs could be a promising cell source for
adoptive cell-based SG therapies, and bioengineering of
34 In this study, we used an
adoptive cell-transfer strategy to define the protective
35 s et al. demonstrate that the combination of
adoptive cellular therapy with CTLA4 blockade induces lo
36 or multi-alphaherpesvirus vaccine design and
adoptive cellular therapy.
37 into circulation, which may be harnessed for
adoptive cellular therapy.
38 of tolerized mice, and depletion of Tregs or
adoptive experiments revealed that Tregs were critically
39 ptible to years of nurturance and support in
adoptive families.
40 rationale to explore combination therapy of
adoptive HSPC-NK cells and DAC in patients with AML.
41 Adoptive immune cell therapy is emerging as a promising
42 munity," not to be confused with adaptive or
adoptive immunity.
43 ALL in vivo, and support the development of
adoptive immunotherapeutic approaches with BCR-ABL CTLs
44 ion combines cytoreductive chemotherapy with
adoptive immunotherapy and may cure patients who fail ch
45 Adoptive immunotherapy is a potentially curative therape
46 Adoptive immunotherapy using chimeric antigen receptor (
47 Adoptive immunotherapy using receptor engineering to ach
48 Adoptive immunotherapy utilizing chimeric antigen recept
49 ple myeloma patients and have been used with
adoptive immunotherapy with gammadelta T cells expressin
50 Adoptive immunotherapy with genetically engineered T cel
51 Adoptive immunotherapy with regulatory T cells (Tregs) i
52 Adoptive immunotherapy with T cells genetically modified
53 lness of recombinant IL-7 as an adjuvant for
adoptive immunotherapy.
54 for the treatment or prevention of PVAN with
adoptive immunotherapy.
55 tion of superior antitumor T cell grafts for
adoptive immunotherapy.
56 o increase the safety and efficacy of cancer
adoptive immunotherapy.
57 ity to generate BK-specific T cell lines for
adoptive immunotherapy.
58 High levels of
adoptive mother positive reinforcement buffered the effe
59 therapy plasma of the AML patients receiving
adoptive NK-92 cell therapy block anti-leukemia cytotoxi
60 ons and argue for implementation of IL-15 in
adoptive NK-cell cancer therapy.
61 From
adoptive reconstitution and mixed bone-marrow chimera st
62 to investigate the therapeutic potential of
adoptive regulatory T cell transfer against tPA-induced
63 ally to enhance the efficacy of vaccines and
adoptive T cell therapies for cancer and infectious dise
64 Adoptive T cell therapies have achieved significant clin
65 next-generation design of receptors used in
adoptive T cell therapies.
66 Adoptive T cell therapy (ACT) with antitumor CTL is a pr
67 ich lymphodepletion enhances the efficacy of
adoptive T cell therapy (ACT).
68 In a mouse model of
adoptive T cell therapy for melanoma, Runx3-deficient CD
69 Adoptive T cell therapy has shown significant clinical s
70 tic cervical cancer after tumor-infiltrating
adoptive T cell therapy.
71 l-inflamed human tumors, we assessed whether
adoptive T cell transfer might overcome failed spontaneo
72 echniques would find sensible application in
adoptive T cell-based immunotherapy.
73 rgeting DGKzeta may leverage the efficacy of
adoptive T-cell and immune checkpoint therapies in leuke
74 ncluding inflammation-mediated resistance to
adoptive T-cell immunotherapy, transcriptionally repress
75 Efforts to improve the efficacy of
adoptive T-cell therapies and immune checkpoint therapie
76 oduct that is easily scalable in contrast to
adoptive T-cell therapies.
77 lls derived from PD-1(+) TILs can be used in
adoptive T-cell therapy (ACT).
78 monstrated the potential clinical benefit of
adoptive T-cell therapy (ATCT) of CMV phosphoprotein 65
79 aking the majority of T cells suboptimal for
adoptive T-cell therapy (ATT).
80 Recently,
adoptive T-cell therapy has shown salvage responses in m
81 have potential translational significance in
adoptive T-cell therapy.
82 d the design of more effective protocols for
adoptive T-cell therapy.
83 led clinically by immunotherapeutics such as
adoptive T-cell transfer and checkpoint blockade.
84 Adoptive T-cell transfer experiment showed that this art
85 Chemotherapy administered before
adoptive T-cell transfer has been shown to enhance the a
86 onate therapy with anti-CTLA-4, anti-PD1, or
adoptive T-cell transfer improved antitumor responses in
87 ation in melanoma patients progressing under
adoptive T-cell transfer or immune checkpoint blockade,
88 apies, such as immune checkpoint blockade or
adoptive T-cell transfer, can lead to durable responses
89 odels using dextran sulfate sodium (DSS) and
adoptive T-cell transfer.
90 competent humans, and hypoxia was reduced by
adoptive TH1 transfer.
91 In
adoptive therapy of disseminated leukemia, CD200R-CD28-t
92 Adoptive transfer and cell depletion studies demonstrate
93 Using a single-cell
adoptive transfer and spleen biopsy method, we found tha
94 kout mixed bone marrow chimera as well as an
adoptive transfer approach, we show that CD4 T cell-intr
95 Finally,
adoptive transfer assays in vivo revealed a reduced anti
96 Increases in the number of Eo-MDSC by
adoptive transfer caused a significant exacerbation of i
97 Vgamma2Vdelta2 T cells for
adoptive transfer displayed central/effector memory and
98 ther administering low-level TLR2 ligands in
adoptive transfer EAE induces TLR2 tolerance and attenua
99 In
adoptive transfer EAE models, Bhlhe40-deficient Th1 and
100 ability of isolated Tregs to inhibit IRI in
adoptive transfer experiments and protected mice from ci
101 Results from
adoptive transfer experiments between WT and CD73(-/-) m
102 BrdU labeling and
adoptive transfer experiments confirm more rapid product
103 increased mortality after LPS challenge, and
adoptive transfer experiments confirmed that neutrophil-
104 In vivo
adoptive transfer experiments further indicated the impo
105 We performed a series of
adoptive transfer experiments in mice to better understa
106 Adoptive transfer experiments revealed that intrahepatic
107 Adoptive transfer experiments revealed that the thymic n
108 Adoptive transfer experiments show that antibiotic admin
109 Adoptive transfer experiments showed reduced airway eosi
110 In our first model,
adoptive transfer experiments were followed by cecal lig
111 A series of
adoptive transfer experiments with genetically engineere
112 ergy and anaphylaxis, various knockout mice,
adoptive transfer experiments, and in vitro assays to id
113 In
adoptive transfer experiments, DN T cells significantly
114 nic function of intestinal DCs was tested by
adoptive transfer experiments, ex vivo hapten presentati
115 In our
adoptive transfer experiments, matrix metalloproteinase-
116 In
adoptive transfer experiments, wild type, but not Tnfa(-
117 ytometry, in vitro proliferation assays, and
adoptive transfer experiments.
118 mation preceded the formation of LLPCs in an
adoptive transfer immunization system, which allowed for
119 in response to TPO, and persist longer after
adoptive transfer in immunodeficient human TPO-transgeni
120 immunospots, cytotoxicity assays as well as
adoptive transfer in NOD/SCID/IL2Rgamma mice were used t
121 shown by pre-treatment of monocytes prior to
adoptive transfer into an on-going murine peritonitis mo
122 from these tissues initiated infection after
adoptive transfer into naive hosts.
123 , our studies suggest that regulatory T cell
adoptive transfer may alleviate thrombolytic treatment-i
124 Thus, regulatory T cell
adoptive transfer may be useful as a cell-based therapy
125 Their selection, expansion, and/or
adoptive transfer may support strategies to eradicate HI
126 tudy, we investigated the role of RIAM in an
adoptive transfer model for type I diabetes and report t
127 functionality of tolDCs was confirmed in the
adoptive transfer model of NOD-SCID mice where tolDCs de
128 We used an
adoptive transfer model to elucidate the kinetics of the
129 In a lymphopaenic mouse
adoptive transfer model, naive Mettl3-deficient T cells
130 er EAU was abrogated by BET inhibitors in an
adoptive transfer model.
131 pacts on the development of colitis using an
adoptive transfer model.
132 llowing in vitro BCR stimulation and in vivo
adoptive transfer models confirmed that Ahr(-/-) B cells
133 row chimeras, conditional knockout mice, and
adoptive transfer models were also used.
134 Moreover,
adoptive transfer of 6-ECDCA- or CDCA-treated donor cell
135 Adoptive transfer of adipose tissue B2 cells (ATB2) from
136 s reduced B-cell lymphopoiesis is rescued by
adoptive transfer of affected HSCs or bone marrow cells
137 Thus,
adoptive transfer of allogeneic T9IL-33 cells offers an
138 Adoptive transfer of allospecific transgenic CD4 T cells
139 ata from animal models has demonstrated that
adoptive transfer of allospecific Tregs offers greater p
140 Adoptive transfer of AMs pretreated with MSC-derived EVs
141 Using
adoptive transfer of anergic B cells with subsequent acu
142 inflammatory to anti-inflammatory ATMs, and
adoptive transfer of AT1-ILCs exacerbated metabolic diso
143 The
adoptive transfer of autologous T cells engineered to ex
144 owledge, this is the first report describing
adoptive transfer of autologous TILs to mediate objectiv
145 Thus, we sought to determine if
adoptive transfer of autologous tumour-infiltrating lymp
146 While
adoptive transfer of B cells in Apoe (-/-) /Baffr (-/-)
147 nsulin resistance, which is recapitulated by
adoptive transfer of B cells, but not purified immunoglo
148 Adoptive transfer of B-1a cells into septic mice signifi
149 This study indicated that the
adoptive transfer of B10 cells alleviated periodontal in
150 pendent manner in response to S. aureus, and
adoptive transfer of B1a cells was protective during acu
151 Adoptive transfer of BM and spleen cells from allergic d
152 Adoptive transfer of BM, but not peripheral, granulocyte
153 ced acute allergic airway inflammation after
adoptive transfer of BMDCs was examined by means of micr
154 Furthermore,
adoptive transfer of c-Src-silenced DCs in mouse tumors
155 In a human skin xenograft transplant model,
adoptive transfer of CAR Tregs alleviated the alloimmune
156 Adoptive transfer of CB1R(-/-) bone marrow to ZDF rats a
157 Adoptive transfer of CD11b(+) pulmonary dendritic cells
158 ncy analgesia, which can be rescued with the
adoptive transfer of CD4(+) or CD8(+) T cells from late-
159 ggest that protection from colitis following
adoptive transfer of CerS6-deficient splenocytes maybe r
160 Adoptive transfer of CerS6-deficient splenocytes, which
161 Adoptive transfer of Chlamydia-specific CD4 TCR-Tg T cel
162 Adoptive transfer of conventional DCs, in particular CD1
163 Adoptive transfer of CRTC2/3m BM conferred the splenomeg
164 himurium was significantly reduced after the
adoptive transfer of CX3CR1(+) cells directly into the i
165 himurium was significantly reduced after the
adoptive transfer of CX3CR1(+) cells directly into the i
166 Adoptive transfer of Cx3cr1-proficient monocyte-enriched
167 osis and bactericidal activity in vitro, and
adoptive transfer of DJ-1(-/-) bone marrow-derived monon
168 The
adoptive transfer of donor-derived viral-specific cytoto
169 Early clinical trials demonstrate that
adoptive transfer of donor-derived virus-specific T cell
170 The
adoptive transfer of engineered T cells for the treatmen
171 Here, we have examined the
adoptive transfer of ex vivo expanded human cord blood-d
172 Adoptive transfer of fluorescently labeled wild-type and
173 Adoptive transfer of forkhead box protein (FOX)3 regulat
174 aused minimal effects in wild-type mice, and
adoptive transfer of gammadelta T cells prevented sensit
175 Purpose
Adoptive transfer of genetically modified T cells is bei
176 In addition,
adoptive transfer of HDAC11KO T cells resulted in signif
177 11c(+) cells (Lrp1(fl/fl); CD11c-Cre) and by
adoptive transfer of HDM-pulsed CD11b(+) DCs from Lrp1(f
178 The
adoptive transfer of HDM-pulsed LRP-1-deficient CD11b(+)
179 ulation of eosinophils in the liver, whereas
adoptive transfer of hepatic ILC2s aggravated liver infl
180 Adoptive transfer of high-affinity chimeric antigen rece
181 odel of allergic asthma, we demonstrate that
adoptive transfer of human act-A-iTr1 cells, both in pre
182 Responses to
adoptive transfer of human Tsp cells into immune-deficie
183 analysis of endogenous T cell responses and
adoptive transfer of IAV-specific memory T cell populati
184 Adoptive transfer of Ifnar(-/-) NK cells into NK cell-de
185 gnancy loss, which could be abrogated by the
adoptive transfer of IL-10(+/+) NK cells and not by IL-1
186 Finally,
adoptive transfer of IL-36R-expressing T cells to IL-36R
187 phoid cells (ILC2) in blood and kidneys, and
adoptive transfer of ILC2 also protected mice from IRI.
188 Adoptive transfer of ILC2s from wild-type mice was perfo
189 Importantly,
adoptive transfer of ILC2s restored eosinophil influx an
190 Adoptive transfer of immune cells from IYIY-I2-BODIPY-tr
191 allergic airway inflammation, we found that
adoptive transfer of IMs isolated from CpG-treated mice
192 Adoptive transfer of in vitro differentiated MCs restore
193 Adoptive transfer of iNKT cells from p47(phox-/-) or NOX
194 Adoptive transfer of LN cells of sensitized mice into re
195 Moreover,
adoptive transfer of lung CD4 TRM cells conferred protec
196 Adoptive transfer of Ly6C(+) monocytes gave rise to PD-L
197 Cell tracking and
adoptive transfer of Ly6c(hi) monocytes showed Bmal1 def
198 e-induced mouse periodontitis model in which
adoptive transfer of M1 macrophages showed a significant
199 Adoptive transfer of M2-like macrophages conferred contr
200 y the enteric pathogen Citrobacter rodentium
Adoptive transfer of macrophage-rich peritoneal cells fr
201 In a BALB/c --> B6 lethal GVHD model,
adoptive transfer of MDSCs from TLI/ATS/CTX-conditioned
202 etely resistant to EAE development following
adoptive transfer of myelin-specific T cells and show su
203 In contrast,
adoptive transfer of neonatal CD71(+) cells into adult r
204 Furthermore,
adoptive transfer of NFAT1-deficient CD4(+) T cells into
205 hed mouse xenograft model of ovarian cancer,
adoptive transfer of NK cells conditioned in the same wa
206 Particularly, the
adoptive transfer of NK cells has garnered attention due
207 functional analyses performed in vivo using
adoptive transfer of OVA-specific OT-II cells into wild-
208 Furthermore,
adoptive transfer of PD-L1(+)/PD-L2(+) AAMvarphis into E
209 Adoptive transfer of PKCdelta-suppressed Mvarphi recapit
210 Additionally, the
adoptive transfer of pre-pubertal peritoneal cells impro
211 ancer, based on oncogenic transformation and
adoptive transfer of primary precursor cells (hepatoblas
212 lammation in an atopic asthma model, whereas
adoptive transfer of proangiogenic progenitor cells from
213 Adoptive transfer of pTregs from mice at low risk of sub
214 hodepleting preparative regimen, followed by
adoptive transfer of purified CD4(+) T cells, retroviral
215 Flow cytometry and
adoptive transfer of purified cells show that antibiotic
216 Adoptive transfer of purified IVIg-generated pTreg prior
217 Studies have demonstrated that the
adoptive transfer of regulatory T cells (Tregs) can medi
218 Adoptive transfer of Sema4c(-/-) CD19(+)CD138(+) cells i
219 Moreover,
adoptive transfer of Sphk2(-/-) (but not Sphk2(-/-)Ifng(
220 Adoptive transfer of splenic B cells into B cell-deficie
221 tricular dilatation and hypertrophy, whereas
adoptive transfer of splenic CD4(+) T cells (and, to a l
222 Adoptive transfer of splenic CD8(+) T cells from OVA-sen
223 Adoptive transfer of splenic DN cells gives rise to CD8a
224 Importantly, results from
adoptive transfer of splenocytes from immunized animals
225 vivo Notch signaling, and demonstrated that
adoptive transfer of such Tregs dramatically suppressed
226 Adoptive transfer of T cells engineered to express a hep
227 Adoptive transfer of T cells from W7-791-immunized mice
228 Adoptive transfer of T cells genetically modified to exp
229 The
adoptive transfer of T cells that have been genetically
230 Finally, the
adoptive transfer of T cells treated ex vivo with a GSK-
231 Treatment of B cell malignancies with
adoptive transfer of T cells with a CD19-specific chimer
232 NOD-Idd22 mice were highly protected against
adoptive transfer of T1D.
233 Adoptive transfer of TCR-transduced T cells significantl
234 Adoptive transfer of TEM8 CAR T cells induced regression
235 drive CF both in vitro and in vivo, whereas
adoptive transfer of Th1 cells, opposite to activated IF
236 Adoptive transfer of Th17/1, but not Th1, cells confers
237 Adoptive transfer of the CD103(+)alpha4beta7(high) subse
238 Adoptive transfer of these CCR5Teff cells significantly
239 Monitoring, selection, expansion, and
adoptive transfer of these NK cells may allow monitoring
240 Importantly,
adoptive transfer of these stabilized iTregs to HSV-1-in
241 Adoptive transfer of Treg cells from vaccinated/ppins-pr
242 rocyte differentiation, which was rescued by
adoptive transfer of Treg.
243 Tregs after BMT also induced cGVHD, whereas
adoptive transfer of Tregs ameliorated it.
244 Consistently,
adoptive transfer of Vgamma2Vdelta2 T cells attenuated T
245 Conversely,
adoptive transfer of VNS-conditioned alpha7nAChR splenoc
246 eatment, platelet inhibition by aspirin, and
adoptive transfer of wild-type (WT) platelets to CD40-KO
247 alveolar lavage fluid IL-4 and IL-5, whereas
adoptive transfer of wild-type CD19(+)CD138(+)IL-10(+) c
248 Adoptive transfer of wild-type or p110delta(D910A) Tregs
249 Adoptive transfer of WT bone marrow-derived hematopoieti
250 AI(-/-) mice following hepatic infection and
adoptive transfer of WT bone-marrow-derived Mvarphi conf
251 Adoptive transfer of WT but not BLT1(-/-) or CXCR3(-/-)
252 on, but can be rescued from mortality by the
adoptive transfer of WT CD4(+) T cells.
253 The
adoptive transfer of WT mast cells restored allergic sym
254 e lack of an effect on parasite replication,
adoptive transfer of WT platelets to CD40-KO mice, which
255 Adoptive transfer of ZIKV-immune CD8(+) T cells reduced
256 y, we use genetic lineage-tracing models and
adoptive transfer protocols to address this question.
257 Abrogation of GM-CSF receptor signaling in
adoptive transfer recipients of MOG35-55-specific T cell
258 MPECs deficient in HVEM failed to survive in
adoptive transfer recipients.
259 In vivo depletion and
adoptive transfer studies identified CD300b-expressing m
260 istribution was disrupted in the spleen, but
adoptive transfer studies indicated that these cells wer
261 Genetic loss of function in mice and
adoptive transfer studies revealed that bone marrow-deri
262 in Treg cells was further dissected through
adoptive transfer studies using CCR8(-/-) mice.
263 Adoptive transfer studies with young T cells demonstrate
264 monkeys also conferred passive protection in
adoptive transfer studies.
265 KIR3DL1(+) NK cells gained reactivity after
adoptive transfer to HLA-B( *)27:05(+) mice or bone marr
266 vo with/without human MSC-derived EVs before
adoptive transfer to LPS-injured mice.
267 erived DC subsets was determined by means of
adoptive transfer to naive mice.
268 TCR-transduced TIL1383I T cells prepared for
adoptive transfer to patients as part of a clinical tria
269 toxicity against tumor cells and safety upon
adoptive transfer to patients.
270 their T cells failed to induce colitis after
adoptive transfer to Rag(-/-) mice.
271 Despite the ability of
adoptive transfer to restore allergic airways inflammati
272 In ROCK2(+/-) mice,
adoptive transfer with CD4(+) cells from OT-II mice rest
273 tor beta knockout mice were reconstituted by
adoptive transfer with CD4+ or CD8+ T-cells subsets were
274 Combining natural killer (NK) cell
adoptive transfer with hypomethylating agents (HMAs) is
275 ted in T-cell receptor beta knockout mice by
adoptive transfer, and bone turnover, bone mineral densi
276 ta inhibition in CD8(+) T cells destined for
adoptive transfer, enhancing their survival and also the
277 These T cells induced diabetes after
adoptive transfer, indicating their pathogenicity.
278 Similarly, in vivo, after
adoptive transfer, Nr4a1-deficient MPPS contribute more
279 ubsets occurred in Pdcd1(-/-) mice and, upon
adoptive transfer, Pdcd1(-/-) KLRG1(+) ILC-2s significan
280 ns to suppress the autoimmune response after
adoptive transfer, thereby avoiding potential overall im
281 n vitro and reduced their ability, following
adoptive transfer, to prime the expansion of Ag-specific
282 ne controlled cortical impact model, we used
adoptive transfer, transgenic, and bone marrow chimera a
283 c cells from DNFB-fed mice to inhibit ACD on
adoptive transfer.
284 he pathogenesis of Pneumocystis pneumonia by
adoptive transfer.
285 protection against Francisella novicida upon
adoptive transfer.
286 134.5 mutant in vivo mediate protection upon
adoptive transfer.
287 rise to intestinal CD8alphaalpha IELs after
adoptive transfer.
288 otective effects of gammadelta T cells after
adoptive transfer.
289 vo modification and expansion of T cells for
adoptive transfer.
290 ry and remodeling, and retain this memory on
adoptive transfer.
291 mained detectable from 6 h through 7 d after
adoptive transfer.
292 muridarum and Chlamydia trachomatis Using an
adoptive-
transfer approach, we show that naive Tg CD4 T
293 Using
adoptive-
transfer experiments and ovariectomized mice, w
294 of NLRX1 specifically in T cells, we used an
adoptive-
transfer model of colitis.
295 sessed the role of T cell-derived CD70 using
adoptive-
transfer models, including autoimmune inflammat
296 Using
adoptive transfers of spleen and lung NK cells, we found
297 Using a combination of knockout mice,
adoptive transfers, and depletion studies, we recently f
298 nerated irradiation chimeras, or carried out
adoptive transfers, with wild-type (WT) and/or MHC I-def
299 In experiments with IDO2-deficient mice,
adoptive transplant experiments demonstrated that IDO2 e
300 Adoptive wild-type leukocyte transfer rescues the thromb